Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement solutions for life science research, pharmaceutical and biotherapeutic development. With more than 130,000 placements in laboratories around the world, the company’s instruments have catalyzed brilliant scientific research described in over 25,000 peer-reviewed publications. Products include powerful platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.
Before joining Danaher in 2010, Molecular Devices had earned a reputation for providing an exceptionally wide range of bioanalytical systems for life science and drug discovery research. Recent innovations include the ImageXpress Micro Confocal High-Content Imaging System, which allows users to capture publication-grade images with the widest range of objective lenses. Leading-edge products like this help scientists unravel the complexity of biological systems, ultimately accelerating research and the discovery of new therapeutics.